Steven R Goldring

Title: The Innovative Contributions of Steven R Goldring

Introduction

Steven R Goldring is a notable inventor based in Auburndale, MA (US). He has made significant contributions to the field of drug delivery systems and molecular biology. With a total of 2 patents, Goldring's work has the potential to impact various medical treatments.

Latest Patents

One of Goldring's latest patents is titled "Macromolecular prodrug-based thermosensitive injectable gel as a novel drug delivery platform." This application discloses a prodrug-based thermosensitive gel, referred to as 'ProGel,' which is comprised of conjugates of dmg molecules with water-soluble polymeric carriers. These carriers are capable of controlled release of the dmg molecules into the tissue of a subject. The patent also discusses the use of ProGel-Drug conjugates for the treatment of various diseases or disorders, along with methods of preparing them. Another significant patent is "Nucleic acids encoding calcitonin receptor and uses thereof." This patent describes recombinant DNA that encodes a calcitonin receptor polypeptide, as well as vectors and hosts containing the recombinant DNA. It also outlines methods for expressing a calcitonin receptor polypeptide from the recombinant DNA.

Career Highlights

Throughout his career, Goldring has worked with esteemed organizations such as The General Hospital Corporation and the Board of Regents of the University of Nebraska. His experience in these institutions has contributed to his expertise in the field of drug delivery and molecular biology.

Collaborations

Goldring has collaborated with notable individuals in his field, including Alan H Gorn and Herb Y Lin. These collaborations have likely enriched his research and development efforts.

Conclusion

Steven R Goldring's innovative work in drug delivery systems and molecular biology showcases his significant contributions to the field. His patents reflect a commitment to advancing medical treatments and improving patient care.